Suppr超能文献

小细胞骨肉瘤与融合驱动型骨小圆细胞肉瘤的回顾性临床、影像学、病理学和(表观遗传学)比较及其临床意义。

Small cell osteosarcoma versus fusion-driven round cell sarcomas of bone: retrospective clinical, radiological, pathological, and (epi)genetic comparison with clinical implications.

机构信息

Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Virchows Arch. 2024 Mar;484(3):451-463. doi: 10.1007/s00428-024-03747-2. Epub 2024 Feb 9.

Abstract

Small cell osteosarcoma (SCOS), a variant of conventional high-grade osteosarcoma (COS), may mimic fusion-driven round cell sarcomas (FDRCS) by overlapping clinico-radiological and histomorphological/immunohistochemical characteristics, hampering accurate diagnosis and consequently proper therapy. We retrospectively analyzed decalcified formalin-fixed paraffin-embedded (FFPE) samples of 18 bone tumors primarily diagnosed as SCOS by methylation profiling, fusion gene analysis, and immunohistochemistry.In eight cases, the diagnosis of SCOS was maintained, and in 10 cases it was changed into FDRCS, including three Ewing sarcomas (EWSR1::FLI1 in two cases and no identified fusion gene in the third case), two sarcomas with BCOR alterations (KMT2D::BCOR, CCNB3::BCOR, respectively), three mesenchymal chondrosarcomas (HEY1::NCOA2 in two cases and one case with insufficient RNA quality), and two sclerosing epithelioid fibrosarcomas (FUS::CREBL3 and EWSR1 rearrangement, respectively).Histologically, SCOS usually possessed more pleomorphic cells in contrast to the FDRCS showing mainly monomorphic cellular features. However, osteoid was seen in the latter tumors as well, often associated with slight pleomorphism. Also, the immunohistochemical profile (CD99, SATB2, and BCOR) overlapped.Clinically and radiologically, similarities between SCOS and FDRCS were observed, with by imaging only minimal presence or lack of (mineralized) osteoid in most of the SCOSs.In conclusion, discrimination of SCOS, epigenetically related to COS, versus FDRCS of bone can be challenging but is important due to different biology and therefore therapeutic strategies. Methylation profiling is a reliable and robust diagnostic test especially on decalcified FFPE material. Subsequent fusion gene analysis and/or use of specific immunohistochemical surrogate markers can be used to substantiate the diagnosis.

摘要

小细胞骨肉瘤(SCOS)是传统高级别骨肉瘤(COS)的一种变体,通过重叠的临床放射学和组织形态学/免疫组织化学特征,可能模仿融合驱动的圆形细胞肉瘤(FDRCS),从而阻碍准确诊断,进而影响适当的治疗。我们通过甲基化谱分析、融合基因分析和免疫组织化学分析,回顾性分析了 18 例最初诊断为 SCOS 的骨肿瘤的脱钙福尔马林固定石蜡包埋(FFPE)样本。在 8 例中,维持了 SCOS 的诊断,而在 10 例中改变为 FDRCS,包括 3 例尤文肉瘤(EWSR1::FLI1 在 2 例,第三例未鉴定融合基因)、2 例 BCOR 改变的肉瘤(KMT2D::BCOR、CCNB3::BCOR,分别)、3 例间叶性软骨肉瘤(HEY1::NCOA2 在 2 例,1 例 RNA 质量不足)和 2 例硬化性上皮样纤维肉瘤(FUS::CREBL3 和 EWSR1 重排)。组织学上,SCOS 通常具有更多的多形性细胞,而 FDRCS 主要表现为单形性细胞特征。然而,后者肿瘤中也可见骨样组织,通常伴有轻微的多形性。此外,免疫组织化学特征(CD99、SATB2 和 BCOR)重叠。临床和放射学上,SCOS 和 FDRCS 之间存在相似之处,在影像学上,大多数 SCOS 中只有极少量或缺乏(矿化)骨样组织。总之,区分与 COS 有表观遗传学相关的 SCOS 与骨的 FDRCS 具有挑战性,但由于生物学不同,因此治疗策略也不同,这很重要。甲基化谱分析是一种可靠且强大的诊断测试,尤其是在脱钙 FFPE 材料上。随后进行融合基因分析和/或使用特定的免疫组织化学替代标志物可以用于证实诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d90/11021258/fe29d9f1de12/428_2024_3747_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验